SOURCE: Fresh Start Private Management Inc.

Fresh Start Private Management Inc.

November 26, 2010 14:07 ET

Fresh Start Private Management, Inc. Appoints Recognized Community Leader Dr. Jorge Andrade Jr. as CEO of the Company

LAS VEGAS, NV--(Marketwire - November 26, 2010) - Fresh Start (OTCBB: CEYY) announces it appointed Dr. Jorge Andrade as CEO and Director of the company.

Effective November 22, 2010, Michael Cetrone resigned as President and Chief Executive Officer, Chief Financial Officer, Secretary, Treasurer and as a member of the Board of Directors of Fresh Start Private Management, Inc. (the "Company").

Concurrent with Mr. Cetrone's resignation, Dr. Jorge Adrade, was appointed Chief Executive Officer, Chief Financial Officer, Secretary and Treasurer. Dr. Andrade was already a member of the Board of Directors of the Company.

Dr. Jorge Andrade Jr. is founder, CEO and President of West Coast Consulting Inc. since 2004. Dr. Andrade is a licensed Doctor of Dental Surgery and National Dental Board Certified since 1998. One of Dr. Andrade's current positions is Senior Program Co-coordinator for the Western Division of Colgate Palmolive "Bright Smiles Bright Futures Dental Program." Dr. Andrade is a Licensed Medical Interpreter, a licensed Doctor of Dental Surgery since 1995, and co-founder of TM Cube Medical LLC. Dr. Andrade has exceptional knowledge of starting, building and managing small businesses.

Effective November 22, 2010 the Board of Directors appoints Neil Muller as President.

Neil Muller is one of the world's leaders in alcohol treatment and recovery and the architect of the Fresh Start Private Program. Mr. Muller has treated over 5,000 patients worldwide and will now focus his efforts on directing the clinics in America to cure the 18 million alcoholics across the country.

About Fresh Start Private™

Fresh Start Private is a company on the leading edge for the treatment of alcohol addiction. The Company's founder has treated over 5,000 patients. Fresh Start is the only alcohol treatment program in the world to offer a single-administration, long acting, Naltrexone implant™. The non-invasive Naltrexone implant is placed just under the skin in the patient's abdominal area. The procedure takes about 20 minutes and in nearly every instance patients are released the same day.

For more information, visit www.freshstartprivate.com.

Statements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations, estimates and projections about the company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors, including those described above and those risks discussed from time to time in Fresh Start filings with the Securities and Exchange Commission. 

Contact Information

  • Jorge Andrade
    CEO
    1 714 541 6100